
    
      Adeno-associated virus serotype 9 carrying the human NAGLU gene under the control of a CMV
      enhancer/promoter (rAAV9.CMV.hNAGLU) will be delivered one-time through a venous catheter
      inserted into a peripheral limb vein. A tapering course of prophylactic enteral prednisone or
      prednisolone will be administered for a period of at least two months.
    
  